Assyro AI

Orange Book product · Generic (ANDA)

NEOMYCIN AND POLYMYXIN B SULFATE

NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Generic (ANDA)ANDA 065106RX XGEN PHARMS

At a glance

Jan 31, 2006

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 31, 2006

    20 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Strength

EQ 40MG BASE/ML;200,000 UNITS/ML

Dosage form

SOLUTION

Route

IRRIGATION

TE code

Not listed

Application

ANDA 065106

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Active-ingredient family

View full family

Generic (ANDA) of NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.